AIM Vaccine Co

AIM Vaccine Co Interest Coverage

The Interest Coverage Ratio of AIM Vaccine Co (6660.HK) as of Oct 30, 2026 is -4.45. In the previous year, Interest Coverage Ratio was -108.19 — a change of -95.88% (higher).

Interest Coverage

-4.45

YoY

-95.88%

Last updated:

Interest Coverage Ratio of AIM Vaccine Co is 2024 -4.45 . Interest Coverage Ratio of AIM Vaccine Co was 2023 -108.19 . It decreases by -95.88% higher compared to the previous year.

The AIM Vaccine Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2019
26.42 CNY
Jan 1, 2020
200.65 CNY
Jan 1, 2021
-170.72 CNY
Jan 1, 2022
-35.22 CNY
Jan 1, 2023
-108.19 CNY
Jan 1, 2024
-4.45 CNY
The AIM Vaccine Co Interest Coverage history
YEARInterest CoverageYoY
-4.45-95.88%
-108.19+207.16%
-35.22-79.37%
-170.72-185.08%
200.65+659.51%
26.42—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

AIM Vaccine Co Stock analysis

What does AIM Vaccine Co do? AIM Vaccine Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AIM Vaccine Co stock

Interest Coverage Ratio of AIM Vaccine Co is -4.45 in 2024.

Interest Coverage Ratio of AIM Vaccine Co changed from -108.19 to -4.45, representing a -95.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio AIM Vaccine Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's AIM Vaccine Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — AIM Vaccine Co

All Key Metrics — AIM Vaccine Co